Mecasermin rinfabate Pregnancy and Breastfeeding Warnings
Brand names: iPlex
Mecasermin rinfabate Pregnancy Warnings
Mecasermin rinfabate has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal evidence of embryofetal toxicity or teratogenicity. There are no controlled data in human pregnancy. Mecasermin rinfabate is only recommended for use during pregnancy when benefit outweighs risk.
Mecasermin rinfabate Breastfeeding Warnings
There are no data on the excretion of mecasermin rinfabate into human milk. The manufacturer recommends that caution be used when administering mecasermin rinfabate to nursing women.
References for pregnancy information
- "Multum Information Services, Inc. Expert Review Panel"
References for breastfeeding information
- "Multum Information Services, Inc. Expert Review Panel"
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
